Masimo | MASI - Spese Operative



Spese Operative Cambiamento Data
Abbott USD 11.66B 1.2B 2026-09
Accuray USD 37.18M 567K 2024-12
Align Technology USD 821.72M 43.15M 2026-09
AngioDynamics USD 81.95M 1.68M 2025-09
Artivion USD 111.2M 9.45M 2025-12
AtriCure USD 143.94M 3.22M 2026-06
Baxter International USD 6.5B 3.82B 2026-09
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Boston Scientific USD 4.13B 72M 2026-09
Dexcom USD 990.1M 53.5M 2026-06
Edwards Lifesciences USD 1.22B 87.6M 2026-06
General Electric Aerospace USD 17.52B 118M 2026-09
Globus Medical USD 835.58M 239.73M 2026-06
Haemonetics USD 145.34M 148.66M 2026-06
Inogen USD 49.14M 665K 2024-09
Insulet USD 672M 32.3M 2026-06
Integra LifeSciences USD 368.53M 674.84M 2026-09
Intuitive Surgical USD 2B 86.5M 2026-09
Medtronic USD 7.92B 203M 2026-06
Orthofix International USD 213.79M 12.36M 2025-12
Owens Minor USD -550.94M 86.17M 2026-06
ResMed USD 1.01B 83.57M 2026-06
Steris USD 1.21B 62.8M 2026-06
Stryker USD 4.8B 118M 2026-06
Tandem Diabetes Care USD 268.35M 3.7M 2026-06
Teleflex USD 2.9B 179.9M 2026-06
Thermo Fisher Scientific USD 9.68B 134M 2026-09
Zimmer Biomet Holdings USD 1.83B 140.7M 2026-06